MEDICINOVA, INC. (MNOV) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value $950.50K; Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value (m); Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | $950.50K | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Reported amount: $950.50K |
| Deferred revenue · latest quarter (USD) | (m) | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due within 1 year (USD) | (m) | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due after 1 year (USD) | (m) | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Total reported obligations | 3.16M USD | Liabilities |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Amounts owed to suppliers | 950.50K USD | Accounts Payable, Current |
| Total deferred revenue | (m) | Deferred Revenue · Contract with Customer, Liability, Current · Deferred Revenue, Current · Deferred Revenue, Noncurrent |
| Deferred revenue due within one year | 0.00 USD | Contract with Customer, Liability, Current · Deferred Revenue, Current |
| Deferred revenue due after one year | (m) | Deferred Revenue, Noncurrent · Deferred Revenue · Contract with Customer, Liability, Current · Deferred Revenue, Current |
| Reported other obligations due within one year | (m) | |
| Reported other noncurrent obligations | 0.00 USD | Other Liabilities, Noncurrent |
| Deferred revenue included in other noncurrent obligations | (m) | Deferred Revenue · Contract with Customer, Liability, Current · Deferred Revenue, Current |
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- (m)
- Other obligations · due after 1 year (USD)
- (m)
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Operating lease obligations | $117.04K |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $950.50K | (m) | (m) | (m) | $3.16M | (m) | $0.00 | (m) | $0.00 | (m) |
| 2026-03-31 | (m) | $852.37K | (m) | (m) | (m) | $3.30M | (m) | $428.28K | (m) | $0.00 | (m) |
| 2025-12-31 | (m) | $625.00K | (m) | (m) | (m) | $4.02M | (m) | $370.16K | (m) | $17.13K | (m) |
| 2025-09-30 | (m) | $745.96K | (m) | (m) | (m) | $3.61M | (m) | $521.90K | (m) | $74.40K | (m) |
| 2025-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $500.00K | (m) | (m) | (m) |
| 2025-06-30 | (m) | $569.45K | (m) | (m) | (m) | $2.97M | (m) | (m) | (m) | $117.04K | (m) |
| 2025-03-31 | (m) | $718.89K | (m) | (m) | (m) | $2.50M | (m) | (m) | (m) | $165.20K | (m) |
| 2024-12-31 | (m) | $1.10M | (m) | (m) | (m) | $3.37M | (m) | (m) | (m) | $211.46K | (m) |
| 2024-09-30 | (m) | $708.20K | (m) | (m) | (m) | $3.05M | (m) | (m) | (m) | $255.15K | (m) |
| 2024-06-30 | (m) | $667.70K | (m) | (m) | (m) | $3.00M | (m) | (m) | (m) | $302.48K | (m) |
| 2024-03-31 | (m) | $804.76K | (m) | (m) | (m) | $3.06M | (m) | (m) | (m) | $351.19K | (m) |
| 2023-12-31 | (m) | $1.00M | (m) | (m) | (m) | $3.89M | (m) | (m) | (m) | $410.66K | (m) |
| 2023-09-30 | (m) | $736.90K | (m) | (m) | (m) | $3.47M | (m) | (m) | (m) | $463.84K | (m) |
| 2023-06-30 | (m) | $548.22K | (m) | (m) | (m) | $3.54M | (m) | (m) | (m) | $519.68K | (m) |
| 2023-03-31 | (m) | $585.07K | (m) | (m) | (m) | $3.41M | (m) | (m) | (m) | $489.38K | (m) |
| 2022-12-31 | (m) | $424.65K | (m) | (m) | (m) | $3.91M | (m) | (m) | (m) | $523.62K | (m) |
| 2022-09-30 | (m) | $552.72K | (m) | (m) | (m) | $5.29M | (m) | (m) | (m) | $555.84K | (m) |
| 2022-06-30 | (m) | $642.63K | (m) | (m) | (m) | $4.63M | (m) | (m) | (m) | $587.40K | (m) |
| 2022-03-31 | (m) | $665.25K | (m) | (m) | (m) | $3.81M | (m) | (m) | (m) | $632.87K | (m) |
| 2021-12-31 | (m) | $402.74K | (m) | (m) | (m) | $3.73M | (m) | (m) | (m) | $694.67K | (m) |
| 2021-09-30 | (m) | $642.42K | (m) | (m) | (m) | $5.14M | (m) | $1.69M | (m) | $737.72K | (m) |
| 2021-06-30 | (m) | $607.15K | (m) | (m) | $87.01K | $4.45M | (m) | (m) | $1.69M | $87.01K | $0.00 |
| 2021-03-31 | (m) | $428.15K | (m) | (m) | $2.21K | $3.73M | (m) | (m) | $1.69M | $2.21K | $0.00 |
| 2020-12-31 | (m) | $616.63K | (m) | (m) | $2.71K | $4.09M | (m) | (m) | $1.69M | $2.71K | $0.00 |
| 2020-09-30 | (m) | $376.27K | (m) | (m) | $39.89K | $3.74M | (m) | (m) | $1.69M | $39.89K | $0.00 |
| 2020-06-30 | (m) | $576.51K | (m) | (m) | $75.78K | $4.75M | (m) | (m) | $1.69M | $75.78K | $0.00 |
| 2020-03-31 | (m) | $377.50K | (m) | (m) | $127.61K | $3.82M | (m) | (m) | $1.69M | $127.61K | $0.00 |
| 2019-12-31 | (m) | $451.33K | (m) | (m) | $186.36K | $4.31M | (m) | (m) | $1.69M | $186.36K | $0.00 |
| 2019-09-30 | (m) | $230.38K | (m) | (m) | $243.40K | $3.87M | (m) | (m) | $1.69M | $243.40K | $0.00 |
| 2019-06-30 | (m) | $328.16K | (m) | (m) | $284.27K | $3.97M | (m) | (m) | $1.69M | $284.27K | $0.00 |
| 2019-03-31 | (m) | $254.11K | (m) | (m) | $240.41K | $3.51M | (m) | (m) | $1.69M | $240.41K | $0.00 |
| 2018-12-31 | (m) | $616.75K | (m) | (m) | (m) | $4.12M | (m) | (m) | $1.69M | (m) | $0.00 |
| 2018-09-30 | (m) | $608.28K | (m) | (m) | (m) | $3.72M | (m) | (m) | $1.69M | (m) | $0.00 |
| 2018-06-30 | (m) | $351.87K | (m) | (m) | (m) | $3.49M | (m) | (m) | $1.69M | (m) | $0.00 |
| 2018-03-31 | (m) | $361.41K | (m) | (m) | (m) | $3.09M | (m) | (m) | $1.69M | (m) | $0.00 |
| 2017-12-31 | (m) | $1.52M | (m) | (m) | (m) | $4.78M | (m) | (m) | $1.69M | (m) | $0.00 |
| 2017-09-30 | (m) | $301.71K | (m) | (m) | (m) | $5.39M | (m) | (m) | $1.69M | (m) | $0.00 |
| 2017-06-30 | (m) | $300.41K | (m) | (m) | (m) | $5.07M | (m) | (m) | $1.69M | (m) | $0.00 |
| 2017-03-31 | (m) | $158.14K | (m) | (m) | (m) | $4.67M | (m) | (m) | $1.69M | (m) | $0.00 |
| 2016-12-31 | (m) | $367.27K | (m) | (m) | (m) | $5.28M | (m) | (m) | $1.69M | (m) | $0.00 |
| 2016-09-30 | (m) | $265.58K | (m) | (m) | (m) | $5.03M | (m) | (m) | $1.69M | (m) | $0.00 |
| 2016-06-30 | (m) | $209.72K | (m) | (m) | (m) | $4.99M | (m) | (m) | $1.69M | (m) | $0.00 |
| 2016-03-31 | (m) | $77.12K | (m) | (m) | (m) | $4.72M | (m) | (m) | $1.69M | (m) | $0.00 |
| 2015-12-31 | (m) | $170.79K | (m) | (m) | (m) | $5.15M | (m) | (m) | $1.69M | (m) | $0.00 |
| 2015-09-30 | (m) | $354.70K | (m) | (m) | (m) | $4.96M | (m) | (m) | $1.69M | (m) | $0.00 |
| 2015-06-30 | (m) | $177.56K | (m) | (m) | (m) | $4.77M | (m) | (m) | $1.69M | (m) | $0.00 |
| 2015-03-31 | (m) | $110.38K | (m) | (m) | (m) | $4.52M | (m) | (m) | $1.69M | (m) | $0.00 |
| 2014-12-31 | (m) | $461.97K | (m) | (m) | (m) | $5.26M | (m) | (m) | $1.69M | (m) | $0.00 |
| 2014-09-30 | (m) | $317.69K | (m) | (m) | (m) | $4.80M | (m) | (m) | $1.69M | (m) | $0.00 |
| 2014-06-30 | (m) | $38.03K | (m) | (m) | (m) | $4.76M | (m) | (m) | $1.69M | (m) | $0.00 |
| 2014-03-31 | (m) | $153.87K | (m) | (m) | (m) | $4.57M | (m) | (m) | $1.69M | (m) | $0.00 |
| 2013-12-31 | (m) | $33.89K | (m) | (m) | (m) | $4.12M | (m) | (m) | $1.69M | (m) | $0.00 |
| 2013-09-30 | (m) | $186.89K | (m) | (m) | (m) | $4.75M | (m) | (m) | $1.69M | (m) | $0.00 |
| 2013-06-30 | (m) | $130.82K | (m) | (m) | (m) | $4.73M | (m) | (m) | $1.69M | (m) | $0.00 |
| 2013-03-31 | (m) | $269.86K | (m) | (m) | (m) | $4.60M | (m) | (m) | $1.69M | (m) | $0.00 |
| 2012-12-31 | (m) | $491.85K | $1.70M | (m) | (m) | $4.69M | (m) | $3.16K | $1.69M | (m) | $0.00 |
| 2012-09-30 | (m) | $333.00K | $1.73M | (m) | (m) | $4.80M | (m) | $45.25K | $1.69M | (m) | $0.00 |
| 2012-06-30 | (m) | $440.11K | (m) | (m) | (m) | $5.16M | (m) | $1.82M | (m) | (m) | (m) |
| 2012-03-31 | (m) | $309.42K | $2.31M | (m) | (m) | $6.33M | (m) | $672.34K | $1.64M | (m) | $0.00 |
| 2011-12-31 | (m) | $718.88K | $2.50M | (m) | (m) | $7.29M | (m) | $863.51K | $1.64M | (m) | $0.00 |
| 2011-09-30 | (m) | $1.08M | (m) | (m) | (m) | $5.39M | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | $329.34K | (m) | (m) | (m) | $4.41M | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $1.10M | (m) | (m) | (m) | $48.23M | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |